Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Artra GroupTSE:6029 -2.91%59 Gross Margin % is 0.00% as of Dec. 2025. GuruFocus rates TSE:6029 with a GF Score™ of 59/100 and a GF Value™ of 円140.45 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 631 Healthcare Providers & Services companies, Artra Group ranks worse than 56.42% on this metric.
The historical rank and industry rank for Artra Group's Gross Margin % or its related term are showing as below:
TSE:6029'
s Gross Margin % Range Over the Past 10 Years
Min: 20.54 Med: 33.68 Max: 38.25
Current: 35.16
During the past 13 years, the highestGross Margin % of Artra Group was 38.25%. The lowest was 20.54%. And the median was 33.68%.
TSE:6029's Gross Margin % is ranked worse than 56.42% of 631
companies
in the Healthcare Providers & Services industry
Industry Median: 39.96
vs TSE:6029: 35.16
Artra Group had a gross margin of N/A% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Artra Group was 8.70% per year.
Artra Group (TSE:6029) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Artra Group had a gross margin of N/A% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Artra Group Gross Margin % Related Terms
Artra Group Gross Margin % Historical Data
* Premium members only.
The historical data trend for Artra Group's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6029 vs HCA, THC, DVA: Gross Margin % Comparison
For the Medical Care Facilities subindustry, Artra Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Artra Group Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Artra Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Artra Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Artra Group (TSE:6029) has a Gross Margin % of 0.00% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Artra Group and its competitors. Over the past decade, Artra Group's Gross Margin % has ranged from 20.54 to 38.25. According to the industry distribution chart, Artra Group ranks #356 out of 631 companies in the Healthcare Providers & Services industry, placing it in the top 56.4%.
Is Artra Group's Gross Margin % too high?
Artra Group's current Gross Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 20.54 to a high of 38.25. Based on the distribution chart, Artra Group ranks #356 out of 631 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Artra Group has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Artra Group's Gross Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Artra Group ranks #356 out of 631 companies for Gross Margin %. This places Artra Group in the lower half of its industry. The industry median Gross Margin % is 39.96. Historically, Artra Group's own Gross Margin % has ranged from 20.54 to 38.25 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 39.96, based on 631 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Artra Group and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 39.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artra Group's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artra Group stock overvalued right now?
Based on GuruFocus' analysis, Artra Group (TSE:6029) is currently considered Significantly Overvalued. The stock's GF Value™ is 円140.45, compared to a current price of 円200.00 — trading 42.4% above its estimated fair value. The current Gross Margin % is 0.00%. Artra Group's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Artra Group (TSE:6029), the current Gross Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Artra Group (TSE:6029) Overvalued in 2026?
Based on GuruFocus' analysis, Artra Group stock appears to be overvalued.
The current stock price of 円200.00 is trading 42.4% above its estimated GF Value™ of 円140.45.
GuruFocus considers Artra Group to be Significantly Overvalued.
Key valuation signals for TSE:6029:
Gross Margin %: 0.00%
GF Value™: 円140.45 vs. price of 円200.00 (42.4% above fair value)
No single metric tells the full story. See the TSE:6029 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Artra Group Corp is engaged in the healthcare support business, providing services that assist the operation and management of clinics and related facilities. The group has two reportable segments: Acupuncture & Orthopedic Clinic Support and Toy Sales Business. The Acupuncture and Orthopedic Clinic Support segment is involved in supporting acupuncture and orthopedic clinics through services such as bone setting chains, provision of equipment and consumables, Attra billing services, HONEY-STYLE, and nursing care support. The Toy Sales segment focuses on the sale of toys, stationery, and other related products.
59GF Score
Get the complete analysis for TSE:6029
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6029 has been successfully added to your 
